Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus

Description

Clinical Trial to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects with Keratoconus.

Conditions

Progressive Keratoconus

Talk to us

Study Overview

On this page

Study Details

Study overview

Clinical Trial to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects with Keratoconus.

A Dose Ranging, Multicenter, Sham-Controlled Study to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus

Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus

Condition
Progressive Keratoconus
Intervention / Treatment

-

Contacts and Locations

Dothan

Glaukos Investigative Site, Dothan, Alabama, United States, 36301

Teaneck

Glaukos Investigative Site, Teaneck, New Jersey, United States, 07666

Westerville

Glaukos Investigative Site, Westerville, Ohio, United States, 43082

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Provide written informed consent
  • * Ability to hold gaze sufficiently stable for study testing
  • * Willingness and ability to follow all instructions and comply with schedule for follow-up visits
  • * Have a diagnosis of keratoconus
  • * Known allergy or sensitivity to the test articles or components
  • * Any disease causing abnormal topography other than keratoconus
  • * Prior or current ocular condition (other than keratoconus) in the study eye that may predispose the eye for future complications

Ages Eligible for Study

18 Years to 55 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Glaukos Corporation,

Study Record Dates

2026-02